Cargando…
ASPIRIN BENEFIT IS NOT AFFECTED BY BODY WEIGHT IN HEALTHY OLDER PERSONS
Recent meta-analysis (Rothwell et al, Lancet 2018;392:387-99) of aspirin trials in predominantly middle-aged people suggested that aspirin’s effects on clinical outcomes vary according to dose and body weight, concluding that under dosing in heavier people may be responsible for reduced efficacy of...
Autores principales: | Woods, Robyn L, Polekhina, Galina, Nelson, Mark, Wolfe, Rory, Ernst, Michael E, Murray, Anne M, McNeil, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6845084/ http://dx.doi.org/10.1093/geroni/igz038.480 |
Ejemplares similares
-
ANTI-A AND SARS-COV-2: AN INTRIGUING ASSOCIATION
por: Dutra, V.F., et al.
Publicado: (2020) -
The Effect of Low-Dose Aspirin on Frailty in Older Adults in the Aspirin in Reducing Events in the Elderly Study
por: Espinoza, Sara, et al.
Publicado: (2021) -
PALLIATIVE CARE NEEDS ASSESSMENT OF A RURAL AND FRONTIER STATE
por: Carrico, Catherine, et al.
Publicado: (2019) -
A HOSPICE COLLABORATIVE NETWORK TO IMPROVE SERIOUS ILLNESS CARE IN A LARGE HEALTHCARE SYSTEM
por: Leiter, Richard E, et al.
Publicado: (2019) -
ALIVIADO DEMENTIA CARE-HOSPICE EDITION: FEASIBILITY AND ACCEPTABILITY RESULTS OF A TWO-PHASED PILOT STUDY
por: Lin, Shih-Yin, et al.
Publicado: (2019)